摘要:
The invention relates to a method for treating or preventing headaches, migraine, or cluster headache. Said method comprises jointly administering a therapeutically effective amount of a selected CGRP antagonist (A), a physiologically acceptable salt thereof or a hydrate of said salt, and a therapeutically effective amount of a second or third active antimigraine medical substance (B), particularly sumatriptan, zolmitriptan, or dihydroergotamine or a physiologically acceptable salt thereof. Also disclosed are the corresponding pharmaceutical compositions and the production thereof.
摘要:
The invention relates to a method for the treatment or prevention of headaches, migraines or cluster headaches, said method including the combined administration of a therapeutically active quantity of the hydrochloride of the active ingredient base 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]-carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine (A) and a therapeutically active quantity of the migraine active ingredient sumatriptan or a physiologically compatible salt thereof. The invention also relates to the corresponding pharmaceutical compositions and to the production of the same.